Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gabriella Dias-Florencio"'
Autor:
Catia M. Pereira, Marco Aurelio M. Freire, José R. Santos, Joanilson S. Guimarães, Gabriella Dias-Florencio, Sharlene Santos, Antonio Pereira, Sidarta Ribeiro
Publikováno v:
PeerJ, Vol 6, p e5678 (2018)
Background Historically, the primary sensory areas of the cerebral cortex have been exclusively associated with the processing of a single sensory modality. Yet the presence of tactile responses in the primary visual (V1) cortex has challenged this v
Externí odkaz:
https://doaj.org/article/660f0195efc54a6984060ba73ade46f4
Autor:
Gabriella Dias Florencio, Guillaume Precigout, Cyriaque Beley, Pierre-Olivier Buclez, Luis Garcia, Rachid Benchaouir
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 2, Iss , Pp - (2015)
Recombinant adeno-associated viruses (rAAV) are promising candidates for gene therapy approaches. The last two decades were particularly fruitful in terms of processes applied in the production and purification of this type of gene transfer vectors.
Externí odkaz:
https://doaj.org/article/4b292448e03f4d25996b5f5abceaeb4b
Publikováno v:
Genes
Genes, Vol 8, Iss 2, p 51 (2017)
Genes, Vol 8, Iss 2, p 51 (2017)
RNA plays complex roles in normal health and disease and is becoming an important target for therapeutic intervention; accordingly, therapeutic strategies that modulate RNA function have gained great interest over the past decade. Antisense oligonucl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b37a23c42bdc8ed2eec6d9a093ec883c
https://pubmed.ncbi.nlm.nih.gov/28134780
https://pubmed.ncbi.nlm.nih.gov/28134780
Autor:
Luis Garcia, Cyriaque Beley, Rachid Benchaouir, Gabriella Dias Florencio, Karima Relizani, Pierre-Olivier Buclez
Publikováno v:
Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2016, 3, pp.16035. ⟨10.1038/mtm.2016.35⟩
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods and Clinical Development, 2016, 3, pp.16035. ⟨10.1038/mtm.2016.35⟩
Molecular Therapy: Methods & Clinical Development, Vol 3, Iss C (2016)
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2016, 3, pp.16035. ⟨10.1038/mtm.2016.35⟩
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods and Clinical Development, 2016, 3, pp.16035. ⟨10.1038/mtm.2016.35⟩
Molecular Therapy: Methods & Clinical Development, Vol 3, Iss C (2016)
Recombinant adeno-associated viruses (rAAV) are largely used for gene transfer in research, preclinical developments, and clinical trials. Their broad in vivo biodistribution and long-term efficacy in postmitotic tissues make them good candidates for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4575aed51c4f4087cad6a3d896a642b8
https://hal.archives-ouvertes.fr/hal-02407996
https://hal.archives-ouvertes.fr/hal-02407996
Autor:
Luis Garcia, Guillaume Precigout, Cyriaque Beley, Pierre-Olivier Buclez, Gabriella Dias Florencio, Rachid Benchaouir
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2015, 2, pp.15024. ⟨10.1038/mtm.2015.24⟩
Molecular Therapy: Methods & Clinical Development, Vol 2, Iss, Pp-(2015)
Molecular Therapy-Methods and Clinical Development, 2015, 2, pp.15024. ⟨10.1038/mtm.2015.24⟩
Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2015, 2, pp.15024. ⟨10.1038/mtm.2015.24⟩
Molecular Therapy: Methods & Clinical Development, Vol 2, Iss, Pp-(2015)
Molecular Therapy-Methods and Clinical Development, 2015, 2, pp.15024. ⟨10.1038/mtm.2015.24⟩
Recombinant adeno-associated viruses (rAAV) are promising candidates for gene therapy approaches. The last two decades were particularly fruitful in terms of processes applied in the production and purification of this type of gene transfer vectors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f8cab1442983d10b27a201aa8fc8256
http://europepmc.org/articles/PMC4502676
http://europepmc.org/articles/PMC4502676
Autor:
Pierre-Olivier Buclez, Gabriella Dias Florencio, Karima Relizani, Cyriaque Beley, Luis Garcia, Rachid Benchaouir
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 3, Iss C (2016)
Recombinant adeno-associated viruses (rAAV) are largely used for gene transfer in research, preclinical developments, and clinical trials. Their broad in vivo biodistribution and long-term efficacy in postmitotic tissues make them good candidates for
Externí odkaz:
https://doaj.org/article/43627864dc784cb48d1b0d46711c26f0